In early 2020, Social Security Administration Commissioner Andrew Saul engaged in several stock transactions that appear to have anticipated market reactions to the coronavirus crisis, according to financial disclosure forms.
Specifically, Saul made seemingly prescient investments in Abbott Laboratories, UnitedHealth, thecloud workflow company ServiceNow and Eurofins, a foreign company that manufactures personal protective equipment (PPE) for health care workers, among other things.
Though Saul — a wealthy New York businessman with prior government service and decades of financial expertise — has a substantial and diverse portfolio, the timing of the transactions, together with his activity in the administration and investment experience, is intriguing. Continue reading.